Alcohol detox for Deerfield Beach — CIWA-Ar-guided, medically supervised, discretion assured.

RECO Island's Delray Beach campus is 13 miles and 22 minutes north of Deerfield Beach — close enough to keep family involved, far enough to break the environment that supports daily drinking. The alcohol detox unit is physician-led, nurse-staffed 24/7, and uses CIWA-Ar-triggered benzodiazepine protocols with parenteral thiamine from day one. Detox transitions directly into on-campus residential treatment with no waitlist and no third-party handoff — the gap where most people relapse simply doesn't exist here.

Deerfield Beach sits 13 miles south of RECO Island’s Delray Beach campus — roughly 22 minutes north on A1A or I-95. For residents of The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, and Goldcoast Centre, that short trip is far enough to interrupt the routines and relationships that sustain daily drinking without cutting anyone off from family, employers, or attorneys. Alcohol detox at RECO Island is a physician-led, nurse-staffed medical protocol — not a wellness stay — built around the one substance withdrawal syndrome with a documented mortality risk.

Alcohol withdrawal is the one that can kill you

Opioid and stimulant withdrawal are miserable but rarely lethal. Alcohol withdrawal is a different clinical problem. Unmanaged, it carries a real risk of generalized tonic-clonic seizures, delirium tremens, arrhythmias, aspiration, and cardiovascular collapse. Historical case series place mortality in untreated severe alcohol withdrawal at 5-15%; with contemporary medical management that figure drops below 1%. Those numbers are why medical detox is the standard of care for alcohol use disorder — not a preference, not an upsell.

Risk stratification at intake shapes staffing, medication choice, and monitoring intensity. The strongest single predictor of complicated withdrawal is a prior history of withdrawal seizures or delirium tremens. Other risk factors — high daily alcohol volume (typically more than a fifth of liquor or its equivalent), long duration of daily use, age over 60, concurrent benzodiazepine or barbiturate use, and medical comorbidities including cirrhosis, cardiomyopathy, electrolyte disturbance, or uncontrolled hypertension — inform the treatment plan before the first dose is written.

Clients arriving from Deerfield Beach are assessed against the ASAM Criteria’s six dimensions, with particular attention to Dimension 1 (withdrawal potential). A client with two prior DTs and a morning blood alcohol level over 200 mg/dL is a fundamentally different clinical picture from a first-time detox with mild tremor, and the protocol has to reflect that. It also drives the decision on whether inpatient medical detox is appropriate here or whether hospital-level care is required first.

CIWA-Ar and symptom-triggered benzodiazepine dosing

The Clinical Institute Withdrawal Assessment for Alcohol, revised — CIWA-Ar — is the validated instrument used to quantify withdrawal severity at the bedside. It scores ten symptom domains: nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, orientation and clouding of sensorium, tactile disturbances, auditory disturbances, visual disturbances, and headache. Nursing rescores at defined intervals — every hour in high-acuity clients, every 2-4 hours as symptoms stabilize.

Benzodiazepines remain the workhorse of alcohol withdrawal management because of GABA-A cross-tolerance with ethanol. RECO Island selects between chlordiazepoxide, lorazepam, and diazepam based on hepatic function, age, and clinical picture. Long-acting agents like chlordiazepoxide and diazepam self-taper and reduce breakthrough symptoms; lorazepam is preferred in clients with impaired hepatic metabolism because it clears through glucuronidation rather than oxidative pathways affected by cirrhosis.

Symptom-triggered dosing — benzodiazepine administered when CIWA-Ar crosses a defined threshold, typically 8-10 — consistently outperforms fixed-schedule dosing across shorter treatment duration, lower cumulative benzodiazepine exposure, and fewer complications in randomized comparisons. Adjuncts including gabapentin, clonidine, and thiamine are used per protocol. Antipsychotics such as quetiapine or olanzapine are not used as monotherapy in withdrawal because they lower the seizure threshold; they may be added for agitation only after benzodiazepine loading is adequate.

Thiamine, folate, and Wernicke prevention

Chronic heavy alcohol use depletes thiamine (vitamin B1) through poor intake, gastrointestinal malabsorption, and increased metabolic demand. Untreated thiamine deficiency in a withdrawing patient can produce Wernicke’s encephalopathy — the classic triad of ophthalmoplegia, ataxia, and confusion — which, if missed, progresses to Korsakoff’s syndrome and permanent anterograde amnesia. The neurologic damage does not reverse.

RECO Island’s admission protocol includes parenteral thiamine 100 mg IM or IV on day one, continued daily through the detox stay, along with folate 1 mg, a multivitamin, and magnesium replacement. Hypomagnesemia is common in heavy drinkers and independently lowers the seizure threshold, so magnesium is checked and corrected empirically rather than reactively. Thiamine is administered before any dextrose-containing fluids to avoid precipitating Wernicke’s in a marginally deficient patient. This is not optional and it is not a wellness gesture — it is the standard of care, and skipping it is a documentable clinical error.

MAT initiation during detox and the transition to residential

Detox alone is not treatment for alcohol use disorder. The one-year relapse rate for detox-only care is above 70%. RECO Island’s model transitions clients directly from medical detox into on-campus residential treatment — no third-party handoff, no waitlist, no gap during which relapse tends to happen. Discharge from detox to home, in this population, is the intervention with the worst evidence base and it is not the plan here.

Medication-assisted treatment options for alcohol use disorder are discussed during detox and often initiated before discharge to residential. Naltrexone — oral 50 mg daily or the long-acting injectable formulation Vivitrol 380 mg IM every four weeks — is a mu-opioid antagonist that reduces the reinforcing effects of alcohol; it requires a 7-10 day opioid-free window, which the detox stay reliably provides. Acamprosate 666 mg three times daily is initiated after abstinence is stabilized and modulates glutamatergic tone. Disulfiram remains an option for select clients with strong external monitoring.

Concurrent psychiatric medications — sertraline or escitalopram for co-occurring depression, buspirone or hydroxyzine for anxiety without abuse potential, aripiprazole or quetiapine for bipolar spectrum presentations, occasionally lithium where clinically indicated — are managed by the medical team during detox so that residential treatment begins with a stable regimen rather than an unresolved psychiatric workup. Motivational interviewing (MI), cognitive behavioral therapy (CBT), and relapse prevention groundwork begin in the last days of detox and continue seamlessly into residential.

What admission looks like from Deerfield Beach

Most Deerfield Beach admissions arrive by car or arranged transport from The Cove, Hillsboro Beach, or Cresthaven and are in-house within 45 minutes of the first phone call. Intake includes a physician history and physical, ASAM Criteria assessment, baseline labs (CBC, CMP, magnesium, phosphorus, GGT, lipase, PT/INR, urine drug screen, urine pregnancy where applicable, and hepatitis serologies), an EKG, and psychiatric screening with instruments including the PHQ-9, GAD-7, and where indicated the CIWA-Ar and COWS.

The census is deliberately small. Nursing is on the unit 24/7, physicians are on call and round daily, and family members — with a signed release — receive structured clinical updates rather than being left to guess from a distance of thirteen miles.

Insurance and admissions from Deerfield Beach

RECO Island works with major commercial plans including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BlueCross BlueShield. Verification of benefits is completed by phone before admission, and the admissions team reports expected out-of-pocket cost — deductible, coinsurance, and any prior authorization requirements — rather than deferring the question to billing after the stay. Self-pay rates are quoted transparently for clients who prefer not to run detox through insurance for confidentiality reasons.

Serving residents of: The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, Goldcoast Centre.